We are live on ! Find out more
SLNOW

Soleno Therapeutics, Inc. Series A Warrant
SLNOW

Delisted

SLNOW was delisted on the 8th of November, 2019.

Back to rankings

5 hedge funds and large institutions have $22K invested in Soleno Therapeutics, Inc. Series A Warrant in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$11.5K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$5.5K
3
TSS
Two Sigma Securities
New York
+$2.48K
4
BG
Bollard Group
Massachusetts
+$2.01K
5
UBS Group
UBS Group
Switzerland
+$1.7K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
1
Virtu KCG Holdings
New York
$11K +$11.5K +12,531 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$5K +$5.5K +6,000 New
UBS Group
3
UBS Group
Switzerland
$2K +$1.7K +1,859 New
BG
4
Bollard Group
Massachusetts
$2K +$2.01K +2,197 New
TSS
5
Two Sigma Securities
New York
$2K +$2.48K +2,706 New

SLNOW Hedge Fund Activity: Q2 2017 in Review

5 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics, Inc. Series A Warrant (SLNOW) for Q2 2017, worth a combined $22K.

Buyers outnumbered sellers: 5 funds opened new SLNOW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $11.5K.

  • 5 institutional investors held Soleno Therapeutics, Inc. Series A Warrant (SLNOW) as of Q2 2017, up from 0 in Q1 2017.
  • Funds reported $22K of Soleno Therapeutics, Inc. Series A Warrant stock for Q2 2017.
  • 5 funds opened new Soleno Therapeutics, Inc. Series A Warrant positions in Q2 2017 and 0 closed out, a net change of +5 holders.
  • The largest Soleno Therapeutics, Inc. Series A Warrant buyer in Q2 2017 was Virtu KCG Holdings, an estimated $11.5K added.

Based on aggregated 13F filings for Q2 2017.